AOD9604: Research Summary and How to Judge a Supplier
Growth hormone fragment 176-191 studied for lipolytic activity, with human trial data. This profile sets out what is actually published, what a 5mg vial should cost, and the specific documentation to ask for before ordering AOD9604 from any research supplier.
5mg
Typical vial
$44
Lowest tracked
$62
Median price
70
Vendors listing
What AOD9604 is
AOD9604 is the C-terminal 176-191 fragment of human growth hormone, developed as a lipolytic agent and taken through human obesity trials that ultimately failed to separate from placebo on the primary endpoint.
That negative result is useful information rather than a reason to ignore the compound: it means the honest research question is narrower than the marketing suggests.
What the evidence base looks like
There is a real published record behind this compound, spread across animal work and a smaller amount of human data, but not enough controlled evidence to support confident claims.
Our library records roughly 41 relevant publications for AOD9604 and grades the evidence as moderate. That grade describes the weight of research, not a judgement about safety or effect, and it is reviewed as new work is published.
Supplier quality: what to check on AOD9604
The disulfide bridge at the C-terminus is essential and is a common failure point in cheaply synthesised batches.
The practical checklist is the same on every product but weighted differently here: a batch-matched certificate of analysis, an identity method appropriate to this molecule rather than purity alone, clear peptide content per 5mg vial, and a supplier that will answer a technical question before taking payment.
Typical UK pricing
The lowest price we currently track for a 5mg vial is £43.95, against a market median nearer £62. Compare on price per milligram rather than per vial, because vial sizes across suppliers are rarely identical.
A listing well below the tracked low is worth investigating rather than celebrating. On this compound the cost of doing it properly is largely analytical, and that is the first thing an unusually cheap supplier stops paying for.
Frequently asked
Is AOD9604 approved for human use?
No. Everything listed here is supplied for laboratory research use only, and nothing on this page is medical advice.
How much should AOD9604 cost?
Tracked UK prices start around £43.95 for a 5mg vial, with the market median closer to £62.
What is the single most useful check on AOD9604?
The disulfide bridge at the C-terminus is essential and is a common failure point in cheaply synthesised batches.
Search focus for this profile
aod9604 — Tracked monthly searches, difficulty Monitored. Source: Semrush (UK database).
Supporting terms covered: aod9604 review, buy aod9604 uk, aod9604 price, best aod9604 supplier.
Everything below describes published research and market data. Nothing here is medical advice, and none of these compounds are sold or supplied by CheckALab.
More in Metabolic
Semaglutide
GLP-1 receptor agonist with a large human clinical trial record in metabolic research.
Tirzepatide
Dual GIP/GLP-1 agonist studied in large randomized metabolic endpoints.
Retatrutide
Triple agonist with phase 2 metabolic results published and phase 3 ongoing.
Survodutide
GLP-1 and glucagon dual agonist with published phase 2 metabolic and liver outcomes.
5-Amino-1MQ
Small-molecule NNMT inhibitor studied in adipocyte and metabolic models.
Liraglutide
First-generation GLP-1 agonist with a large clinical trial literature behind it.
Lipo-C
Lipotropic compounded solution of methionine, inositol, choline and B vitamins.
Mazdutide
GLP-1 and glucagon dual agonist based on oxyntomodulin, with phase 3 data in China.
MOTS-c
Mitochondrial-derived peptide studied in exercise metabolism and insulin sensitivity models.